Anti-CD3 Inhibits Circulatory and Tissue-resident Memory CD4 T Cells that Drive Asthma Exacerbations in Mice.
Gurupreet S SethiDonald T GraciasRinkesh K GuptaDaniel CarrHaruka MikiRicardo da Silva AntunesMichael CroftPublished in: Allergy (2023)
Anti-CD3 F(ab')2 administration at the time of allergen exposure represents a viable strategy for limiting the immediate activity of allergen-responding memory T cells and asthma exacerbations.